This is consistent with recent studies demonstrating inhibition of breast cancer invasion using SIN3 interacting domain decoy peptides and small molecule inhibitors of SIN3 that inhibit both SIN3A and SIN3B [16, 17]. This evidence concerns the gene SIN3A and breast carcinoma.